Nouf E. Alotaibi
Mecca, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Montelukast Versus Gabapentin for Uremic Pruritus in Twice-Weekly Hemodialysis Patients: A 52-Week Prospective Non-Randomized Open-Label Comparative Study.
Journal: Hemodialysis international. International Symposium on Home Hemodialysis
Published: March 14, 2026
Recurrent and Multidrug-Resistant UTI Treatments in Kidney Transplant Patients: A Retrospective Study from Saudi Arabia.
Journal: Antibiotics (Basel, Switzerland)
Published: August 18, 2025
Herbal Medicine Use Among Transplant Recipients in Saudi Arabia: Prevalence and Risk Awareness.
Journal: Annals of transplantation
Published: March 04, 2025
Antifungal drug discovery for targeting Candida albicans morphogenesis through structural dynamics study.
Journal: Journal of biomolecular structure & dynamics
Published: April 18, 2024
Antiviral actions of natural compounds against dengue virus RNA dependent RNA polymerase: insights from molecular dynamics and Gibbs free energy landscape.
Journal: Journal of biomolecular structure & dynamics
Published: March 05, 2024
CYP3A5 Polymorphisms Leading to Tacrolimus Toxicity Following an Adult Renal Transplant.
Journal: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
Published: January 17, 2024
Bioprospecting of Meliaceae family phytomolecules for the treatment of monkeypox virus infection: a QSAR modeling and MD simulation approach.
Journal: Journal of biomolecular structure & dynamics
Published: January 04, 2024
Incidence and risk factors of infections following kidney transplantation.
Journal: Journal of infection and public health
Published: October 18, 2023
Humoral and Cellular Immunity following Five Doses of COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis.
Journal: Vaccines
Published: April 15, 2023
Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection.
Journal: Medicina (Kaunas, Lithuania)
Published: April 01, 2023
Last Updated: 09/26/2026